DANAE STEPHENS: Open Payments
NPI 1083187595 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$536 in 24 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $119 · 2025 $536
Food & beverage: $536
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 4 | $75 |
| Janssen Biotech, Inc. | 3 | $67 |
| Astellas Pharma US Inc | 3 | $67 |
| Genmab U.S., Inc. | 2 | $51 |
| ABBVIE INC. | 2 | $51 |
| Incyte Corporation | 1 | $30 |
| PUMA BIOTECHNOLOGY, INC. | 1 | $29 |
| GENZYME CORPORATION | 1 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
| Aveo Pharmaceuticals, Inc. | 1 | $22 |
Products named: KEYTRUDA, VENCLEXTA, Xtandi, CARVYKTI, JAKAFI, NERLYNX, AYVAKIT, FRUZAQLA.
Industry payments across KY — which companies pay providers there.
